Table 2.
Comparison of outcomes between coronavirus disease 2019 positive and coronavirus disease 2019 negative cohorts
|
Outcome
|
Analysis
|
Negative (n = 146), n (%)
|
Positive (n = 51), n (%)
|
Odds ratio2 (95%CI)
|
P
value
|
| Intensive care | Unadjusted | 8 (5) | 14 (27) | 6.53 (2.55, 16.7) | < 0.001 |
| Admission | Adjusted1 | - | - | 4.64 (1.59, 13.5) | 0.005 |
| 30-d mortality | Unadjusted | 14 (10) | 15 (29) | 3.93 (1.74, 8.89) | 0.001 |
| Adjusted1 | - | - | 3.00 (1.22, 7.40) | 0.02 | |
| Negative (n = 146), Med [IQR] | Positive (n = 51), Med [IQR] | Hazard ratio2 (95%CI) | |||
| Length of stay | Unadjusted | 9 [7, 13] | 23 [19, 31] | 0.28 (0.18, 0.42) | < 0.001 |
| (d) | Adjusted1 | - | - | 0.26 (0.17, 0.42) | < 0.001 |
1
Adjusted for: gender, mobility, admission haemoglobin, operative time and time from admission to surgery.
2
Expressed as outcome in the coronavirus disease 2019 (COVID-19) positive group relative to the outcome in the COVID-19 negative group.